Vaidya Sane Ayurved Laboratories H1 FY27 Results: Net Loss of ₹0.2 Cr
Vaidya Sane Ayurved Laboratories Ltd reported revenue from operations of ₹58.7 Cr (+17.6% YoY) and a net loss of ₹0.2 Cr for H1 FY27.
- Key figure
- Net loss ₹0.2 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Vaidya Sane Ayurved Laboratories Ltd reported revenue from operations of ₹58.7 Cr (+17.6% YoY) and a net loss of ₹0.2 Cr for H1 FY27.
The Company has filed an undertaking confirming that Corporate Governance provisions under Regulation 27 of SEBI (LODR) are not applicable for the current quarter.
Vaidya Sane Ayurved Laboratories held its 27th AGM on September 30, 2026. Shareholders considered the adoption of financial results, auditor re-appointments, and approval of ESOP 2026.
Vaidya Sane Ayurved Laboratories will hold its 27th Annual General Meeting on September 30, 2026, via video conferencing. The company also filed its FY 2025-26 Annual Report.
The company's board approved the 27th AGM details, director/auditor re-appointments, an increase in MD remuneration, and the introduction of the 'VSALL - ESOP 2026' scheme.
Vaidya Sane Ayurved Laboratories filed a statement of deviation or variation in fund utilization pursuant to Regulation 32(1) for the quarter ended June 30, 2026.